23-4467
4th Cir.Jan 21, 2025Background
- Dr. Anita Jackson, an otolaryngologist, operated a multi-location medical practice in North Carolina and was the top Medicare biller nationally for balloon sinuplasty surgeries.
- She reused single-use medical devices (the Entellus XprESS tool) for treating Medicare patients, contrary to FDA labeling and industry practice, and inadequately sanitized them.
- Jackson was audited multiple times for her practices, leading to uncovered record falsification, backdated patient declarations with forged signatures, and extensive Medicare overbilling.
- A grand jury indicted Jackson on 20 counts, including violation of the Food, Drug, and Cosmetics Act (FDCA), anti-kickback statute violations, making false statements, aggravated identity theft, mail fraud, and conspiracy.
- Jackson was convicted on all counts, sentenced to 25 years in prison, and ordered to pay restitution. She appealed her FDCA and aggravated identity theft convictions, as well as related trial rulings and jury instructions.
- The Fourth Circuit reviewed the case, addressing preserved and unpreserved objections under plain-error review.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether reusing and reselling single-use devices is "holding for sale" under FDCA § 331(k) | Jackson argued devices were not "held for sale" because not transferred in ownership to patients | Government argued that providing devices in paid medical services meets the "held for sale" standard | Court affirmed: reusing single-use devices in a commercial medical practice is "held for sale" under § 331(k) |
| Whether FDCA § 396's physician exception shields Jackson from liability | Jackson argued § 396 prevents prosecution of physicians for off-label use in doctor-patient relationships | Government argued § 396 only protects lawful off-label use, not use of adulterated devices | Court affirmed: § 396 does not apply to use of adulterated devices, prosecution proper |
| Whether her conviction relied on an invalid per se adulteration theory (re-use equals adulteration) | Jackson argued that reusing a single-use device is not automatically adulteration and labeling is not law | Government argued conviction rested on inadequate cleaning and real contamination, not simply label violation | Court affirmed: conviction based on devices being adulterated due to cleaning/contamination, not mere label re-use |
| Whether the aggravated identity theft convictions survive Dubin v. United States | Jackson argued Dubin narrowed § 1028A; her forged patient signatures were not the crux of the fraud | Government argued forged declarations were essential to the fraud (the "who" was central) | Court affirmed: facts present classic aggravated identity theft falling within § 1028A, unlike Dubin |
Key Cases Cited
- United States v. Kaplan, 836 F.3d 1199 (9th Cir. 2016) ("Held for sale" applies to physicians reusing single-use devices in commercial settings under the FDCA)
- United States v. Olano, 507 U.S. 725 (1993) (Establishes the standard for plain-error review)
- Buckman Co. v. Plaintiffs’ Legal Comm., 531 U.S. 341 (2001) (Defines protected off-label use under § 396 and its limitations)
- Dubin v. United States, 599 U.S. 110 (2023) (Limits aggravated identity theft under § 1028A to situations where identity use is at the heart of the fraud)